VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q67488253 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241120235938.0
008 241120nneanz||abbn n and d
035 ‎‡a (WKP)Q67488253‏
024 ‎‡a 0000-0002-6048-8744‏ ‎‡2 orcid‏
024 ‎‡a 57193677401‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q67488253‏
100 0 ‎‡a Schneider HG‏ ‎‡9 ast‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a Hans Gerhard Schneider‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Schneider HG‏ ‎‡c investigador‏ ‎‡9 es‏
400 0 ‎‡a Schneider HG‏ ‎‡c onderzoeker‏ ‎‡9 nl‏
670 ‎‡a Author's A comparison between high resolution serum protein electrophoresis and screening immunofixation for the detection of monoclonal gammopathies in serum‏
670 ‎‡a Author's A new in vitro bioassay for human calcitonin: validation and comparison to the rat hypocalcemia bioassay.‏
670 ‎‡a Author's Action of calcitonin gene-related peptide at the calcitonin receptor of the T47D cell line‏
670 ‎‡a Author's Age-related reference intervals for bone turnover markers from an Australian reference population.‏
670 ‎‡a Author's Airway iron and iron-regulatory cytokines in cystic fibrosis‏
670 ‎‡a Author's Antioxidant Vitamin Supplements and Markers of Bone Turnover in a Community Sample of Nonsmoking Women‏
670 ‎‡a Author's Antithyroid drug treatment of von Basedow's disease: results from a multicenter study‏
670 ‎‡a Author's B-type natriuretic peptide testing and the accuracy of heart failure diagnosis in the emergency department.‏
670 ‎‡a Author's C-reactive protein as a predictor of cardiovascular risk in HIV-infected individuals‏
670 ‎‡a Author's Cardiac Troponin I Concentrations, but Not Electrocardiographic Results, Predict an Extended Hospital Stay after Coronary Artery Bypass Graft Surgery‏
670 ‎‡a Author's Challenges for Detecting Valproic Acid in a Nontargeted Urine Drug Screening Method.‏
670 ‎‡a Author's Common laboratory tests predict imminent death in ward patients.‏
670 ‎‡a Author's Common laboratory tests predict imminent medical emergency team calls, intensive care unit admission or death in emergency department patients.‏
670 ‎‡a Author's Desirable performance standards for HbA(1c) analysis - precision, accuracy and standardisation: consensus statement of the Australasian Association of Clinical Biochemists (AACB), the Australian Diabetes Society (ADS), the Royal College of Pathologi‏
670 ‎‡a Author's High-sensitivity C-reactive protein and fracture risk in elderly women‏
670 ‎‡a Author's How low can we go: high-sensitivity troponin T in patients presenting with chest pain‏
670 ‎‡a Author's Hyperkalaemia with cyclooxygenase-2 inhibition and hypoaldosteronism.‏
670 ‎‡a Author's Impact of High-Sensitivity Troponin I Testing with Sex-Specific Cutoffs on the Diagnosis of Acute Myocardial Infarction.‏
670 ‎‡a Author's Improved sensitivity of point of care troponin I values using reporting to below the 99 th percentile of normals.‏
670 ‎‡a Author's In vitro detection of neutralizing antibodies after treatment of Paget's disease of bone with nasal salmon calcitonin.‏
670 ‎‡a Author's Influence of atrial fibrillation on cardiac brain natriuretic peptide release during haemodynamic stress in heart failure‏
670 ‎‡a Author's Is addition of angiotensin receptor blockade superior to increasing ACE inhibitor dose in patients with heart failure?‏
670 ‎‡a Author's Macrophage migration inhibitory factor for the early prediction of infarct size.‏
670 ‎‡a Author's Myeloma cells can directly contribute to the pool of RANKL in bone bypassing the classic stromal and osteoblast pathway of osteoclast stimulation.‏
670 ‎‡a Author's Near-infrared autofluorescence induced by intraplaque hemorrhage and heme degradation as marker for high-risk atherosclerotic plaques.‏
670 ‎‡a Author's New haemoglobin A1c: the way it is reported is about to change...‏
670 ‎‡a Author's Not a high‐sensitivity troponin T assay‏
670 ‎‡a Author's Overreporting of vitamin D deficiency with the Roche Elecsys Vitamin D3‏
670 ‎‡a Author's Overreporting of vitamin D deficiency with the Roche Elecsys Vitamin D3 (25-OH) method.‏
670 ‎‡a Author's Parathyroid hormone-related protein mRNA and protein expression in multiple myeloma: a case report‏
670 ‎‡a Author's Plasma Macrophage Migration Inhibitor Factor Is Elevated in Response to Myocardial Ischemia‏
670 ‎‡a Author's Predictive performance of different kidney function estimation equations in lung transplant patients.‏
670 ‎‡a Author's Procalcitonin for the clinical laboratory: a review.‏
670 ‎‡a Author's Role of voltage-dependent calcium channels in secretion of calcitonin from human medullary thyroid carcinoma cells‏
670 ‎‡a Author's Screening for disease‏
670 ‎‡a Author's Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption, and fractures: the Geelong Osteoporosis Study.‏
670 ‎‡a Author's Serum selenium status in Graves’ disease with and without orbitopathy: a case-control study‏
670 ‎‡a Author's Should routine laboratories stop doing screening serum protein electrophoresis and replace it with screening immune-fixation electrophoresis? No quick fixes: Counterpoint‏
670 ‎‡a Author's Simultaneous determination of voriconazole, posaconazole, itraconazole and hydroxy-itraconazole in human plasma using LCMS/MS.‏
670 ‎‡a Author's Soluble transferrin receptor and depth of bone marrow suppression following high dose chemotherapy.‏
670 ‎‡a Author's Structural requirements for the action of parathyroid hormone-related protein (PTHrP) on bone resorption by isolated osteoclasts.‏
670 ‎‡a Author's Towards evidence-based use of serum tumour marker requests: an audit of use in a tertiary hospital‏
670 ‎‡a Author's Towards optimising the provision of laboratory services for bone turnover markers.‏
670 ‎‡a Author's Utility of B-type natriuretic peptide as a screen for left ventricular dysfunction in patients with diabetes: response to Epshteyn et al‏
670 ‎‡a Author's What criteria should be used to assess troponin assays?‏
670 ‎‡a Author's β-blockers reduce bone resorption marker in early postmenopausal women‏
909 ‎‡a (orcid) 0000000260488744‏ ‎‡9 1‏
909 ‎‡a (scopus) 57193677401‏ ‎‡9 1‏
919 ‎‡a antioxidantvitaminsupplementsandmarkersofboneturnoverinacommunitysampleofnonsmokingwomen‏ ‎‡A Antioxidant Vitamin Supplements and Markers of Bone Turnover in a Community Sample of Nonsmoking Women‏ ‎‡9 1‏
919 ‎‡a agerelatedreferenceintervalsforboneturnovermarkersfromanaustralianreferencepopulation‏ ‎‡A Age-related reference intervals for bone turnover markers from an Australian reference population.‏ ‎‡9 1‏
919 ‎‡a actionofcalcitoningenerelatedpeptideatthecalcitoninreceptorofthet47dcellline‏ ‎‡A Action of calcitonin gene-related peptide at the calcitonin receptor of the T47D cell line‏ ‎‡9 1‏
919 ‎‡a newinvitrobioassayforhumancalcitoninvalidationandcomparisontotherathypocalcemiabioassay‏ ‎‡A A new in vitro bioassay for human calcitonin: validation and comparison to the rat hypocalcemia bioassay.‏ ‎‡9 1‏
919 ‎‡a airwayironandironregulatorycytokinesincysticfibrosis‏ ‎‡A Airway iron and iron-regulatory cytokines in cystic fibrosis‏ ‎‡9 1‏
919 ‎‡a βblockersreduceboneresorptionmarkerinearlypostmenopausalwomen‏ ‎‡A β-blockers reduce bone resorption marker in early postmenopausal women‏ ‎‡9 1‏
919 ‎‡a whatcriteriashouldbeusedtoassesstroponinassays‏ ‎‡A What criteria should be used to assess troponin assays?‏ ‎‡9 1‏
919 ‎‡a utilityofbtypenatriureticpeptideasascreenforleftventriculardysfunctioninpatientswithdiabetesresponsetoepshteynetal‏ ‎‡A Utility of B-type natriuretic peptide as a screen for left ventricular dysfunction in patients with diabetes: response to Epshteyn et al‏ ‎‡9 1‏
919 ‎‡a towardsoptimisingtheprovisionoflaboratoryservicesforboneturnovermarkers‏ ‎‡A Towards optimising the provision of laboratory services for bone turnover markers.‏ ‎‡9 1‏
919 ‎‡a towardsevidencebaseduseofserumtumourmarkerrequestsanauditofuseinatertiaryhospital‏ ‎‡A Towards evidence-based use of serum tumour marker requests: an audit of use in a tertiary hospital‏ ‎‡9 1‏
919 ‎‡a structuralrequirementsfortheactionofparathyroidhormonerelatedproteinpthrponboneresorptionbyisolatedosteoclasts‏ ‎‡A Structural requirements for the action of parathyroid hormone-related protein (PTHrP) on bone resorption by isolated osteoclasts.‏ ‎‡9 1‏
919 ‎‡a solubletransferrinreceptoranddepthofbonemarrowsuppressionfollowinghighdosechemotherapy‏ ‎‡A Soluble transferrin receptor and depth of bone marrow suppression following high dose chemotherapy.‏ ‎‡9 1‏
919 ‎‡a simultaneousdeterminationofvoriconazoleposaconazoleitraconazoleandhydroxyitraconazoleinhumanplasmausinglcmsms‏ ‎‡A Simultaneous determination of voriconazole, posaconazole, itraconazole and hydroxy-itraconazole in human plasma using LCMS/MS.‏ ‎‡9 1‏
919 ‎‡a shouldroutinelaboratoriesstopdoingscreeningserumproteinelectrophoresisandreplaceitwithscreeningimmunefixationelectrophoresisnoquickfixescounterpoint‏ ‎‡A Should routine laboratories stop doing screening serum protein electrophoresis and replace it with screening immune-fixation electrophoresis? No quick fixes: Counterpoint‏ ‎‡9 1‏
919 ‎‡a serumseleniumstatusingravesdiseasewithandwithoutorbitopathyacasecontrolstudy‏ ‎‡A Serum selenium status in Graves’ disease with and without orbitopathy: a case-control study‏ ‎‡9 1‏
919 ‎‡a seasonalperiodicityofserumvitamin500andparathyroidhormoneboneresorptionandfracturesthegeelongosteoporosisstudy‏ ‎‡A Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption, and fractures: the Geelong Osteoporosis Study.‏ ‎‡9 1‏
919 ‎‡a screeningfordisease‏ ‎‡A Screening for disease‏ ‎‡9 1‏
919 ‎‡a roleofvoltagedependentcalciumchannelsinsecretionofcalcitoninfromhumanmedullarythyroidcarcinomacells‏ ‎‡A Role of voltage-dependent calcium channels in secretion of calcitonin from human medullary thyroid carcinoma cells‏ ‎‡9 1‏
919 ‎‡a procalcitoninfortheclinicallaboratoryareview‏ ‎‡A Procalcitonin for the clinical laboratory: a review.‏ ‎‡9 1‏
919 ‎‡a predictiveperformanceofdifferentkidneyfunctionestimationequationsinlungtransplantpatients‏ ‎‡A Predictive performance of different kidney function estimation equations in lung transplant patients.‏ ‎‡9 1‏
919 ‎‡a plasmamacrophagemigrationinhibitorfactoriselevatedinresponsetomyocardialischemia‏ ‎‡A Plasma Macrophage Migration Inhibitor Factor Is Elevated in Response to Myocardial Ischemia‏ ‎‡9 1‏
919 ‎‡a parathyroidhormonerelatedproteinmrnaandproteinexpressioninmultiplemyelomaacasereport‏ ‎‡A Parathyroid hormone-related protein mRNA and protein expression in multiple myeloma: a case report‏ ‎‡9 1‏
919 ‎‡a overreportingofvitamin500deficiencywiththerocheelecsysvitamind3255method‏ ‎‡A Overreporting of vitamin D deficiency with the Roche Elecsys Vitamin D3 (25-OH) method.‏ ‎‡9 1‏
919 ‎‡a overreportingofvitamin500deficiencywiththerocheelecsysvitamind3‏ ‎‡A Overreporting of vitamin D deficiency with the Roche Elecsys Vitamin D3‏ ‎‡9 1‏
919 ‎‡a notahighsensitivitytroponintassay‏ ‎‡A Not a high‐sensitivity troponin T assay‏ ‎‡9 1‏
919 ‎‡a newhaemoglobina1cthewayitisreportedisabouttochange‏ ‎‡A New haemoglobin A1c: the way it is reported is about to change...‏ ‎‡9 1‏
919 ‎‡a nearinfraredautofluorescenceinducedbyintraplaquehemorrhageandhemedegradationasmarkerforhighriskatheroscleroticplaques‏ ‎‡A Near-infrared autofluorescence induced by intraplaque hemorrhage and heme degradation as marker for high-risk atherosclerotic plaques.‏ ‎‡9 1‏
919 ‎‡a myelomacellscandirectlycontributetothepoolofranklinbonebypassingtheclassicstromalandosteoblastpathwayofosteoclaststimulation‏ ‎‡A Myeloma cells can directly contribute to the pool of RANKL in bone bypassing the classic stromal and osteoblast pathway of osteoclast stimulation.‏ ‎‡9 1‏
919 ‎‡a macrophagemigrationinhibitoryfactorfortheearlypredictionofinfarctsize‏ ‎‡A Macrophage migration inhibitory factor for the early prediction of infarct size.‏ ‎‡9 1‏
919 ‎‡a isadditionofangiotensinreceptorblockadesuperiortoincreasingaceinhibitordoseinpatientswithheartfailure‏ ‎‡A Is addition of angiotensin receptor blockade superior to increasing ACE inhibitor dose in patients with heart failure?‏ ‎‡9 1‏
919 ‎‡a influenceofatrialfibrillationoncardiacbrainnatriureticpeptidereleaseduringhaemodynamicstressinheartfailure‏ ‎‡A Influence of atrial fibrillation on cardiac brain natriuretic peptide release during haemodynamic stress in heart failure‏ ‎‡9 1‏
919 ‎‡a invitrodetectionofneutralizingantibodiesaftertreatmentofpagetsdiseaseofbonewithnasalsalmoncalcitonin‏ ‎‡A In vitro detection of neutralizing antibodies after treatment of Paget's disease of bone with nasal salmon calcitonin.‏ ‎‡9 1‏
919 ‎‡a improvedsensitivityofpointofcaretroponin1valuesusingreportingtobelowthe99thpercentileofnormals‏ ‎‡A Improved sensitivity of point of care troponin I values using reporting to below the 99 th percentile of normals.‏ ‎‡9 1‏
919 ‎‡a impactofhighsensitivitytroponin1testingwithsexspecificcutoffsonthediagnosisofacutemyocardialinfarction‏ ‎‡A Impact of High-Sensitivity Troponin I Testing with Sex-Specific Cutoffs on the Diagnosis of Acute Myocardial Infarction.‏ ‎‡9 1‏
919 ‎‡a hyperkalaemiawithcyclooxygenase2inhibitionandhypoaldosteronism‏ ‎‡A Hyperkalaemia with cyclooxygenase-2 inhibition and hypoaldosteronism.‏ ‎‡9 1‏
919 ‎‡a howlowcanwe5highsensitivitytroponintinpatientspresentingwithchestpain‏ ‎‡A How low can we go: high-sensitivity troponin T in patients presenting with chest pain‏ ‎‡9 1‏
919 ‎‡a highsensitivity100reactiveproteinandfractureriskinelderlywomen‏ ‎‡A High-sensitivity C-reactive protein and fracture risk in elderly women‏ ‎‡9 1‏
919 ‎‡a desirableperformancestandardsforhba1canalysisprecisionaccuracyandstandardisationconsensusstatementoftheaustralasianassociationofclinicalbiochemistsaacbtheaustraliandiabetessocietyadstheroyalcollegeofpathologi‏ ‎‡A Desirable performance standards for HbA(1c) analysis - precision, accuracy and standardisation: consensus statement of the Australasian Association of Clinical Biochemists (AACB), the Australian Diabetes Society (ADS), the Royal College of Pathologi‏ ‎‡9 1‏
919 ‎‡a commonlaboratorytestspredictimminentmedicalemergencyteamcallsintensivecareunitadmissionordeathinemergencydepartmentpatients‏ ‎‡A Common laboratory tests predict imminent medical emergency team calls, intensive care unit admission or death in emergency department patients.‏ ‎‡9 1‏
919 ‎‡a commonlaboratorytestspredictimminentdeathinwardpatients‏ ‎‡A Common laboratory tests predict imminent death in ward patients.‏ ‎‡9 1‏
919 ‎‡a challengesfordetectingvalproicacidinanontargetedurinedrugscreeningmethod‏ ‎‡A Challenges for Detecting Valproic Acid in a Nontargeted Urine Drug Screening Method.‏ ‎‡9 1‏
919 ‎‡a comparisonbetweenhighresolutionserumproteinelectrophoresisandscreeningimmunofixationforthedetectionofmonoclonalgammopathiesinserum‏ ‎‡A A comparison between high resolution serum protein electrophoresis and screening immunofixation for the detection of monoclonal gammopathies in serum‏ ‎‡9 1‏
919 ‎‡a cardiactroponin1concentrationsbutnotelectrocardiographicresultspredictanextendedhospitalstayaftercoronaryarterybypassgraftsurgery‏ ‎‡A Cardiac Troponin I Concentrations, but Not Electrocardiographic Results, Predict an Extended Hospital Stay after Coronary Artery Bypass Graft Surgery‏ ‎‡9 1‏
919 ‎‡a 100reactiveproteinasapredictorofcardiovascularriskinhivinfectedindividuals‏ ‎‡A C-reactive protein as a predictor of cardiovascular risk in HIV-infected individuals‏ ‎‡9 1‏
919 ‎‡a btypenatriureticpeptidetestingandtheaccuracyofheartfailurediagnosisintheemergencydepartment‏ ‎‡A B-type natriuretic peptide testing and the accuracy of heart failure diagnosis in the emergency department.‏ ‎‡9 1‏
919 ‎‡a antithyroiddrugtreatmentofvonbasedowsdiseaseresultsfromamulticenterstudy‏ ‎‡A Antithyroid drug treatment of von Basedow's disease: results from a multicenter study‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 DNB|122057562‏
996 ‎‡2 DNB|1264821328‏
996 ‎‡2 DNB|127487824‏
996 ‎‡2 DNB|173473369‏
996 ‎‡2 NKC|mzk2003199841‏
996 ‎‡2 NKC|stk2008477287‏
996 ‎‡2 NTA|074559273‏
996 ‎‡2 DNB|13259482X‏
996 ‎‡2 RERO|A006381271‏
996 ‎‡2 CAOONL|ncf10930254‏
996 ‎‡2 DNB|117644811‏
996 ‎‡2 DNB|1195493118‏
996 ‎‡2 NUKAT|nx2022755635‏
996 ‎‡2 NII|DA10033720‏
996 ‎‡2 DNB|114003801X‏
996 ‎‡2 DNB|1139192469‏
996 ‎‡2 DE633|pe30023071‏
996 ‎‡2 BNF|17744352‏
996 ‎‡2 RERO|A020093701‏
996 ‎‡2 LIH|LNB:B2_h__z_;=B2‏
996 ‎‡2 LC|n 2013185018‏
996 ‎‡2 SUDOC|080625681‏
996 ‎‡2 DNB|1255738723‏
996 ‎‡2 DNB|173040837‏
996 ‎‡2 DNB|1138583545‏
996 ‎‡2 ISNI|0000000020961651‏
996 ‎‡2 DNB|1021174319‏
996 ‎‡2 J9U|987007342004005171‏
996 ‎‡2 ISNI|0000000010955258‏
996 ‎‡2 PLWABN|9810530668305606‏
996 ‎‡2 DNB|1347502467‏
996 ‎‡2 DNB|1243976063‏
996 ‎‡2 BIBSYS|98053282‏
996 ‎‡2 SUDOC|137773196‏
996 ‎‡2 J9U|987012508935005171‏
996 ‎‡2 NUKAT|n 2008113024‏
996 ‎‡2 PLWABN|9810532249205606‏
996 ‎‡2 DNB|110298225‏
996 ‎‡2 DNB|131761803‏
996 ‎‡2 DNB|1128739313‏
996 ‎‡2 NTA|068613954‏
996 ‎‡2 DE633|pe501140‏
996 ‎‡2 DNB|139027319‏
996 ‎‡2 NUKAT|n 2011214241‏
996 ‎‡2 DNB|139976337‏
996 ‎‡2 SUDOC|083700617‏
996 ‎‡2 RERO|A012338012‏
996 ‎‡2 LIH|LNB:V-55312;=BC‏
996 ‎‡2 ISNI|0000000445082329‏
996 ‎‡2 RERO|A003803163‏
996 ‎‡2 NTA|079103820‏
996 ‎‡2 DNB|123581982‏
996 ‎‡2 DNB|1018184961‏
996 ‎‡2 ICCU|IEIV015716‏
996 ‎‡2 NII|DA06246466‏
996 ‎‡2 NTA|140865330‏
996 ‎‡2 LC|n 93077513‏
996 ‎‡2 DNB|118609521‏
996 ‎‡2 ISNI|0000000425332730‏
996 ‎‡2 NTA|154650773‏
996 ‎‡2 DNB|1037032136‏
996 ‎‡2 RERO|A026125626‏
996 ‎‡2 DNB|1243823593‏
996 ‎‡2 DNB|1107031079‏
996 ‎‡2 DNB|1061738132‏
996 ‎‡2 NUKAT|n 2017079085‏
996 ‎‡2 DNB|138525331‏
996 ‎‡2 DNB|1242917926‏
996 ‎‡2 NUKAT|n 2017215228‏
996 ‎‡2 DNB|117730718‏
996 ‎‡2 DNB|116829354‏
996 ‎‡2 RERO|A023944668‏
996 ‎‡2 BNCHL|10000000000000000127441‏
996 ‎‡2 J9U|987007276991805171‏
996 ‎‡2 ISNI|0000000355682072‏
996 ‎‡2 DNB|125967780‏
996 ‎‡2 SUDOC|160152607‏
996 ‎‡2 DNB|1054618348‏
996 ‎‡2 LC|n 78066878‏
996 ‎‡2 DNB|1164974432‏
996 ‎‡2 DNB|1112486658‏
996 ‎‡2 DNB|128791020‏
996 ‎‡2 DNB|1241994439‏
996 ‎‡2 DNB|173040799‏
996 ‎‡2 RERO|A013146588‏
996 ‎‡2 B2Q|0000441214‏
996 ‎‡2 ISNI|0000000109250215‏
996 ‎‡2 DNB|1055208682‏
996 ‎‡2 DNB|1196851905‏
996 ‎‡2 DE633|pe30038726‏
996 ‎‡2 SUDOC|120807580‏
996 ‎‡2 DNB|1157787282‏
996 ‎‡2 BNE|XX1751907‏
996 ‎‡2 DNB|1344610137‏
996 ‎‡2 DNB|1052497519‏
996 ‎‡2 BAV|495_387073‏
996 ‎‡2 BAV|495_387075‏
996 ‎‡2 LC|no2016145407‏
996 ‎‡2 NUKAT|n 96206116‏
996 ‎‡2 NTA|067745830‏
996 ‎‡2 LC|n 93001341‏
996 ‎‡2 DNB|173039855‏
996 ‎‡2 NTA|074296167‏
996 ‎‡2 J9U|987007279391205171‏
996 ‎‡2 NUKAT|n 97035878‏
996 ‎‡2 NUKAT|n 00091169‏
996 ‎‡2 DNB|1207884324‏
996 ‎‡2 DNB|130281832‏
996 ‎‡2 NII|DA09813234‏
996 ‎‡2 DNB|1043294740‏
996 ‎‡2 DNB|118143875‏
996 ‎‡2 ISNI|0000000034763162‏
996 ‎‡2 SUDOC|258487984‏
996 ‎‡2 ISNI|0000000382934407‏
996 ‎‡2 NTA|130491314‏
996 ‎‡2 ISNI|0000000114744690‏
996 ‎‡2 NKC|mub20241221982‏
996 ‎‡2 DNB|141092351‏
996 ‎‡2 DNB|126794057‏
996 ‎‡2 ISNI|0000000409660697‏
996 ‎‡2 CAOONL|ncf11356356‏
996 ‎‡2 DNB|1055666540‏
996 ‎‡2 DNB|131882961‏
996 ‎‡2 J9U|987007278644905171‏
996 ‎‡2 LC|n 98104707‏
996 ‎‡2 NKC|xx0038883‏
996 ‎‡2 DNB|105284619X‏
996 ‎‡2 NKC|mub20201081276‏
996 ‎‡2 BAV|495_115506‏
996 ‎‡2 DNB|114580330X‏
996 ‎‡2 DNB|103134573‏
996 ‎‡2 ISNI|0000000114777476‏
996 ‎‡2 DNB|139833315‏
996 ‎‡2 SUDOC|257305033‏
996 ‎‡2 DNB|1073478653‏
996 ‎‡2 RERO|A011264002‏
996 ‎‡2 LC|no2010093887‏
996 ‎‡2 LC|nr2004038219‏
996 ‎‡2 RERO|A025603388‏
996 ‎‡2 NTA|393504778‏
996 ‎‡2 DNB|1159110654‏
996 ‎‡2 SUDOC|258134410‏
996 ‎‡2 ISNI|0000000400175492‏
996 ‎‡2 DNB|1031498222‏
996 ‎‡2 DNB|133522350‏
996 ‎‡2 ISNI|0000000015333730‏
996 ‎‡2 DNB|129955388‏
996 ‎‡2 DNB|132718499‏
996 ‎‡2 ISNI|0000000013794031‏
996 ‎‡2 DNB|132594811‏
996 ‎‡2 NTA|067688977‏
996 ‎‡2 DNB|174314965‏
996 ‎‡2 ISNI|0000000373651325‏
996 ‎‡2 RERO|A023089511‏
996 ‎‡2 BIBSYS|90302620‏
996 ‎‡2 ISNI|0000000025921392‏
996 ‎‡2 NUKAT|n 2019011733‏
996 ‎‡2 BIBSYS|90956444‏
996 ‎‡2 SUDOC|270951881‏
996 ‎‡2 ISNI|0000000368974832‏
996 ‎‡2 DNB|1164399837‏
996 ‎‡2 ISNI|0000000497663969‏
996 ‎‡2 LC|no2003021849‏
996 ‎‡2 ISNI|000000008371317X‏
996 ‎‡2 SIMACOB|73128291‏
996 ‎‡2 DNB|1054199620‏
996 ‎‡2 DNB|1019536276‏
996 ‎‡2 SUDOC|078007984‏
996 ‎‡2 NUKAT|n 2009123866‏
996 ‎‡2 ISNI|0000000108039522‏
996 ‎‡2 NDL|00455677‏
996 ‎‡2 LC|n 84001278‏
996 ‎‡2 DNB|1013269551‏
996 ‎‡2 SUDOC|238243192‏
996 ‎‡2 DNB|1264159900‏
996 ‎‡2 BIBSYS|1062254‏
996 ‎‡2 DNB|1209973596‏
996 ‎‡2 DNB|1030069085‏
996 ‎‡2 ISNI|0000000395236616‏
996 ‎‡2 LC|no 98035618‏
996 ‎‡2 ISNI|0000000116380384‏
996 ‎‡2 DNB|173040578‏
996 ‎‡2 LIH|LNB:BL_i_V;=B_j_‏
996 ‎‡2 NYNYRILM|16465‏
996 ‎‡2 DE633|pe50050005‏
996 ‎‡2 J9U|987007362655005171‏
996 ‎‡2 SIMACOB|108498787‏
996 ‎‡2 DNB|172553288‏
996 ‎‡2 BIBSYS|97015439‏
996 ‎‡2 ISNI|0000000116531162‏
996 ‎‡2 DNB|120259273‏
996 ‎‡2 DNB|142373583‏
996 ‎‡2 LC|n 80098276‏
996 ‎‡2 DNB|1136602097‏
996 ‎‡2 DNB|133928322‏
996 ‎‡2 DNB|138187525‏
996 ‎‡2 DNB|140531610‏
996 ‎‡2 LC|no2008069699‏
996 ‎‡2 RERO|A024708078‏
996 ‎‡2 J9U|987007316553305171‏
996 ‎‡2 NKC|mub2018988682‏
996 ‎‡2 DNB|1145988164‏
996 ‎‡2 DNB|116825073‏
996 ‎‡2 DNB|1068938196‏
996 ‎‡2 DNB|1015350887‏
996 ‎‡2 DNB|1313658502‏
996 ‎‡2 DNB|120303388‏
996 ‎‡2 DNB|112402803X‏
996 ‎‡2 DNB|172398517‏
996 ‎‡2 NUKAT|n 02047501‏
996 ‎‡2 LC|n 91019449‏
996 ‎‡2 DNB|103759751‏
996 ‎‡2 DNB|130417556‏
996 ‎‡2 DNB|139673415‏
996 ‎‡2 DNB|1253323305‏
996 ‎‡2 DE633|pe51013760‏
996 ‎‡2 DNB|1198898763‏
996 ‎‡2 LC|no2016050962‏
996 ‎‡2 DNB|1074891848‏
996 ‎‡2 PLWABN|9811718232905606‏
996 ‎‡2 RERO|A023952377‏
996 ‎‡2 SUDOC|031947476‏
996 ‎‡2 DNB|1113215747‏
996 ‎‡2 DNB|1159411735‏
996 ‎‡2 DE633|pe251974‏
996 ‎‡2 DNB|1122696272‏
996 ‎‡2 NUKAT|n 2014143914‏
996 ‎‡2 RERO|A012462924‏
996 ‎‡2 ISNI|0000000496522929‏
996 ‎‡2 DNB|1267602678‏
996 ‎‡2 ISNI|0000000107735171‏
996 ‎‡2 DNB|1024227316‏
996 ‎‡2 DNB|1058276239‏
996 ‎‡2 RERO|A017008162‏
996 ‎‡2 DNB|1082245550‏
996 ‎‡2 NKC|jx20090525008‏
996 ‎‡2 NUKAT|n 2013186335‏
996 ‎‡2 DNB|127394443‏
996 ‎‡2 J9U|987007280779605171‏
996 ‎‡2 DNB|115738630X‏
996 ‎‡2 ISNI|0000000374311664‏
996 ‎‡2 NTA|138261261‏
996 ‎‡2 BNC|981058514717606706‏
996 ‎‡2 NUKAT|nx2023938495‏
996 ‎‡2 DNB|142563153‏
996 ‎‡2 LC|no2016092111‏
996 ‎‡2 NTA|151504849‏
996 ‎‡2 ISNI|0000000419301970‏
996 ‎‡2 DNB|125819889‏
996 ‎‡2 LC|n 86040254‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏